StockSelector.com
  Research, Select, & Monitor Saturday, July 21, 2018 9:47:30 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
ACADIA Pharmaceuticals Inc.$16.84($.24)(1.41%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  ACADIA Pharmaceuticals Inc. vs Biotechnology

Acadia Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Their three clinical programs are ACP-103 for treatment-induced dysfunction in Parkinson's disease, and ACP-104 and ACP-103, both for the treatment of schizophrenia.




An exciting industry consisting of companies who develop new drugs to combat such diseases as cancer and other life-threatening diseases. Some may also participate in gene therapy. These firms either bring new drugs to the market themselves (which is a grueling process) or they sell their technology to bigger pharmaceutical companies.
 Totals Company Industry
  Sales: $124.9 Mil $92,223.0 Mil
  Market Cap: $2,100.4 Mil $521,999.2 Mil
  Analysts Recommendation: Strong Buy Buy

 Averages Company Industry
 Growth
  Historic Revenue: 620.7% 44.1%
  Estimated Revenue: 107.7% 145.4%
  Historic Earnings: N/A (41.7%)
  Estimated Earnings: N/A 8.7%
  Stock Price (1 Year): (41.9%) 59.2%
  Cash per Share: (58.6%) 17.4%
  Dividend: N/A N/A
 Price
  Trailing PE: N/A N/A
  Forward PE: N/A 48.4
  Price-to-Sales: 13.3 N/A
  Price-to-Book: 6.2 4.8
  Dividend Yield: N/A N/A
  Market Cap: $2,100.4 Mil $11,347.8 Mil
  Operations
  Net Margin: (161.4%) (2,117.0%)
  Gross Margin: 92.7% 75.7%
  Return on Equity: (.9) (.3)
  Return on Assets: (.8) (.3)
  Balance Sheet
  Current Ratio: 7.6 5.0
  Quick Ratio: 7.5 4.7
  Cash Ratio: 7.0 4.0
  Debt-to-Equity: .1 1.0
  Interest Coverage: N/A 1.8
 Technicals
  Relative-Strength Index: 47.6 46.1

 Other companies in Biotechnology Price Market Cap
  Amgen, Inc.  (AMGN) $190.49 $138,278.6 Mil
  Gilead Sciences, Inc.  (GILD) $77.37 $102,128.4 Mil
  Biogen Inc.  (BIIB) $358.71 $75,867.2 Mil
  Celgene Corp.  (CELG) $85.10 $65,382.3 Mil
  Regeneron Pharmaceuticals Inc.  (REGN) $367.11 $42,183.1 Mil






Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.